Intracellularly retained V2 vasopressin receptor mutants activate different UPR signalling pathways.

被引：0
|
作者：
Lautz, K.
Grantcharova, E.
Schwieger, I.
Rosenthal, W.
Wiesner, B.
Huebner, N.
Hermosilla, R.
机构：
[1] Charite Univ Med Berlin, Inst Pharmakol, D-14195 Berlin, Germany
[2] Leibniz Inst Mol Pharmakol, D-13125 Berlin, Germany
[3] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2007年 / 375卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
30
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [41] Disease-causing V2 vasopressin receptor mutants induce upir in HEK293 cells
    Lautz, K
    Schwieger, I
    Brandt, U
    Wiesner, B
    Oksche, A
    Hermosilla, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 32 - 33
  • [42] Structural basis of tolvaptan binding to the vasopressin V2 receptor
    Liu, Hong-li
    Zhong, Hai-yang
    Zhang, Yi-xiao
    Xue, Hua-rui
    Zhang, Zheng-shuo
    Fu, Ke-quan
    Cao, Xu-dong
    Xiong, Xiao-chun
    Guo, Dong
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (11) : 2441 - 2449
  • [43] Analysis of vasopressin V2 receptor mutants in partial nephrogenic diabetes insipidus and their functional rescue by pharmacologic chaperones
    Makita, Noriko
    Manaka, Katsunori
    Takahashi, Kazuhiro
    Sato, Junichiro
    Oishi, Atsuro
    Yajima, Yuki
    Hashimoto, Makiko
    Sekine, Koji
    Igarashi, Takashi
    Fujita, Toshiro
    Iiri, Taroh
    ENDOCRINE JOURNAL, 2010, 57 : S623 - S624
  • [44] The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling
    Charest, Pascale G.
    Oligny-Longpre, Genevieve
    Bonin, Helene
    Azzi, Mounia
    Bouvier, Michel
    CELLULAR SIGNALLING, 2007, 19 (01) : 32 - 41
  • [45] Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants
    Morello, JP
    Salahpour, A
    Laperrière, A
    Bernier, V
    Arthus, MF
    Lonergan, M
    Petäjä-Repo, U
    Angers, S
    Morin, D
    Bichet, DG
    Bouvier, M
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07): : 887 - 895
  • [46] Rescue of the cell surface expression of functional vasopressin V2 receptor mutants in nephrogenic diabetes insipidus.
    Robben, JH
    Knoers, NV
    Deen, PMT
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 32A - 32A
  • [47] V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms
    Schoneberg, T
    Schulz, A
    Biebermann, H
    Gruters, A
    Grimm, T
    Hubschmann, K
    Filler, G
    Gudermann, T
    Schultz, G
    HUMAN MUTATION, 1998, 12 (03) : 196 - 205
  • [48] Conivaptan:: A dual receptor vasopressin V1a/V2 antagonist
    Ali, Farhan
    Raufi, M. Adnan
    Washington, Barbara
    Ghali, Jalal K.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (03): : 261 - 279
  • [49] Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresis
    Liu, Jun
    Sharma, Nikhil
    Zheng, Wei
    Ji, Hong
    Tam, Helen
    Wu, Xie
    Manigrasso, Michaele B.
    Sandberg, Kathryn
    Verbalis, Joseph G.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 300 (02) : F433 - F440
  • [50] Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function
    Zhu, XY
    Wess, J
    BIOCHEMISTRY, 1998, 37 (45) : 15773 - 15784
12345